In contrast, in another study involving patients with hepatitis B virus (HBV) infection, there was no significant association between visfatin rs11977021 and the risk of developing HBV-related hepatocellular carcinoma (HBV-HCC) [24]. Here, NAMPT is linked to hepatocellular carcinoma.